Rhythm Pharmaceuticals (RYTM) Invested Capital (2016 - 2025)
Historic Invested Capital for Rhythm Pharmaceuticals (RYTM) over the last 10 years, with Q3 2025 value amounting to $154.4 million.
- Rhythm Pharmaceuticals' Invested Capital rose 127648.68% to $154.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $154.4 million, marking a year-over-year increase of 127648.68%. This contributed to the annual value of $23.3 million for FY2024, which is 8629.23% down from last year.
- Per Rhythm Pharmaceuticals' latest filing, its Invested Capital stood at $154.4 million for Q3 2025, which was up 127648.68% from -$8.1 million recorded in Q2 2025.
- Over the past 5 years, Rhythm Pharmaceuticals' Invested Capital peaked at $380.9 million during Q1 2021, and registered a low of -$8.1 million during Q2 2025.
- Moreover, its 5-year median value for Invested Capital was $197.5 million (2023), whereas its average is $183.9 million.
- Within the past 5 years, the most significant YoY rise in Rhythm Pharmaceuticals' Invested Capital was 127648.68% (2025), while the steepest drop was 12066.44% (2025).
- Quarter analysis of 5 years shows Rhythm Pharmaceuticals' Invested Capital stood at $284.2 million in 2021, then fell by 7.0% to $264.3 million in 2022, then plummeted by 35.76% to $169.8 million in 2023, then tumbled by 86.29% to $23.3 million in 2024, then skyrocketed by 563.4% to $154.4 million in 2025.
- Its Invested Capital was $154.4 million in Q3 2025, compared to -$8.1 million in Q2 2025 and $20.5 million in Q1 2025.